Abdossaleh Zar | Public Health | Excellence in Research Award

Published on by Health Scientists

Prof. Abdossaleh Zar | Public Health | Excellence in Research Award

staff | Persian Gulf University | Iran

Prof. Abdossaleh Zar is a distinguished health scientist renowned for contributions at the intersection of public health, clinical research, and translational medicine. His work spans epidemiology, preventive health, and health systems optimization, with a focus on improving population health outcomes through evidence-based interventions. Throughout his career, he has led multidisciplinary research initiatives, collaborating with international institutions, policy-makers, and healthcare organizations to address pressing health challenges. His research has significantly advanced understanding of disease patterns, health disparities, and innovative approaches to patient care, informing guidelines and policies that enhance community well-being. Recognized for scholarly rigor, Dr. [Name] has authored numerous publications in high-impact journals and his work is widely cited, reflecting both scientific influence and practical relevance. Beyond academia, he actively engages in translating research into actionable solutions, fostering partnerships that bridge science, policy, and practice. His leadership extends to mentoring emerging researchers, shaping the next generation of health professionals, and advocating for global health equity. By integrating rigorous research methodology with a commitment to societal impact, Dr. [Name] continues to drive meaningful advances in health science, contributing to both local and international efforts to promote healthier populations. He has 126 citations from 28 documents with an h-index of 7.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Salehi, O. R., Hosseini, S. A., Farkhaei, F., Farzanegi, P., & Zar, A. (2019). Effects of moderate-intensity endurance training and genistein on brain-derived neurotrophic factor and tumor necrosis factor-α in diabetic rats. Journal of Nutrition, Fasting and Health.

2. Hosseini, S. A., Zar, A. S., Ghasemi, A., Khoradmehr, O., & Farkhaie, F. (2018). Hypoglycemic interactional effects of Coriandrum sativum extract and endurance training in diabetic rats. Iranian Journal of Nutrition Sciences and Food Technology.

3. Salimi Avansar, M., & Zar, A. (2017). Comparing the effect of endurance and high intensity interval trainings on levels of chemerin and protein of C-reactive plasma in obese children. Journal of Arak University of Medical Sciences.

4. Zar, A., Hosseini, S. A., Hosseini, S. E., & Siavashi, N. (2016). The effects of eight weeks of endurance training on BDNF, insulin and insulin resistance in rats. Armaghane Danesh.

5. Jahromi, A. S., Zar, A., Ahmadi, F., Krustrup, P., Ebrahim, K., Hovanloo, F., … (2014). Effects of endurance training on the serum levels of tumour necrosis factor-α and interferon-γ in sedentary men. Immune Network.

Zelimkhan Berikkhanov | Clinical Medicine | Young Researcher Award

Published on by Health Scientists

Mr. Zelimkhan Berikkhanov | Clinical Medicine | Young Researcher Award

Assistant Professor | I.M. Sechenov First Moscow State Medical University | Russia

Dr. Zelimkhan Berikkhanov is a clinician-scientist whose work spans thoracic surgery, pulmonology, infectious diseases, oncology, and public health, with a strong emphasis on developing evidence-based approaches to complex respiratory and surgical disorders. His professional career integrates academic leadership as an assistant professor and methodologist with active clinical responsibilities at the National Medical Research Center for Pulmonology and Sechenov University, where he contributes to advanced surgical care, methodological development, and multidisciplinary education. His research portfolio reflects a diverse and impactful scholarly trajectory, encompassing peer-reviewed studies on tracheal reconstruction, thoracic oncology, diaphragmatic trauma, critical respiratory conditions, chronic obstructive pulmonary disease, COVID-associated pneumonia, nanomaterials in gastrointestinal pathology, digital tools in chronic disease management, and telemedicine in pulmonology. He has collaborated extensively with leading national and international experts, contributing to multi-center investigations, clinical guidelines, and translational research aimed at improving diagnostic accuracy, postoperative outcomes, and respiratory care pathways. His scientific productivity is demonstrated through a broad range of publications across high-quality journals, addressing both fundamental mechanisms and applied clinical innovations. His work on COVID-19 significantly advanced understanding of silent hypoxemia, cavitary lung disease, vibroacoustic therapy, and pharmacologic strategies, while his contributions to thoracic surgery strengthened evidence on complex tracheal and bronchial interventions. His participation in research on artificial intelligence for mortality prediction, biomarkers for pulmonary hypertension, metabolic instability in malignancies, and advanced imaging of the lymphatic system underscores his commitment to cross-disciplinary innovation. Through active collaboration, methodological leadership, and involvement in forward-looking clinical studies, Dr. Berikkhanov has helped shape modern approaches to respiratory medicine and thoracic surgery, generating insights that support better patient outcomes and inform national strategies in pulmonary care. His work continues to influence clinical practice, strengthen scientific networks, and enhance healthcare delivery through integrated, technology-supported, and patient-centered frameworks. He has 62 citations from 27 documents with an h-index of 4.

Profiles:  Scopus | ORCID

Featured Publications

1. Sukhanova, M. A., Muraviev, S. Y., Tarabrin, E. A., Shestakov, A. L., Berikkhanov, Z. G. M., Tarasova, I. A., Razumovsky, V. S., Markov, I. A., & Fabrika, A. P. (2025). The role of “metabolic instability” as a new risk criterion in the pathogenesis of endometrial cancer. Cancers.

2. Nagatkina, O. V., Proshkina, A. A., Makarova, N. M., Sokolova, E. S., Merzhoeva, Z. M., Nikitina, L. Y., Nuralieva, G. S., Berikchanov, Z. G., Ainetdinov, R. M., & Avdeev, S. N. (2025). Digital technologies for outpatient management of patients with chronic obstructive pulmonary disease: Opportunities to reduce the burden of the disease. Russian Journal of Preventive Medicine.

3. Ma, T., Berikkhanov, Z. G., Timashev, P. S., Khristidis, Y. I., Ivanova, M. Y., Ershov, B. P., Liu, T., & Tarabrin, E. A. (2025). A comparative study to evaluate the efficacy of sealants alone and in combination with collagen sheet in a pig isolated lung air leak model. Russian Journal of Operative Surgery and Clinical Anatomy.

4. Razumovsky, V. S., Tarabrin, E. A., Muravyov, S. Y., Berikkhanov, Z. G. M., & Konosevich, D. O. (2025). Diagnostics and visualization of the lymphatic system in clinical practice. Russian Sklifosovsky Journal “Emergency Medical Care.

5. Avdeev, S. N., Gaynitdinova, V. V., Merzhoeva, Z. M., Nuralieva, G. S., Tarabrin, E. A., Berikkhanov, Z. G., Nikitina, L. Y., Gneusheva, T. Y., Sokolova, E. S., Ainetdinov, R. M., et al. (2025). NT-proCNP as a new biomarker of pulmonary hypertension in patients with COPD. Scientific Reports.

Saeed Aghebat Bekheir | Translational Research | Research Excellence Award

Published on by Health Scientists

Dr. Saeed Aghebat Bekheir | Mental Health | Research Excellence Award

PhD Candidate in Toxicology | Tehran University of Medical Sciences | Iran

Dr. Saeed Aghebat Bekheir is a dedicated researcher and PhD candidate in Toxicology at Tehran University of Medical Sciences, working under the mentorship of Prof. Abdollahi. His research focuses on mitochondrial toxicology, cardiotoxicity, and mechanistic modeling of toxin-induced bioenergetic failure, with a particular emphasis on developing therapeutic strategies for aluminum phosphide–induced mitochondrial dysfunction. Dr. Aghebat Bekheir has demonstrated expertise in a wide range of experimental approaches, including in vivo animal studies, cellular and molecular assays, and in vitro toxicological models, integrating mechanistic toxicology with translational research to address acute mitochondrial injury and cardiotoxicity. His scholarly contributions are reflected in several peer-reviewed publications in high-impact journals, and he actively serves as a reviewer for multiple journals in toxicology and biomedical sciences, highlighting his commitment to advancing scientific rigor and dissemination. Collaboratively, he engages in research partnerships within the toxicology and mitochondrial research community, fostering interdisciplinary approaches to environmental and translational toxicology challenges. His work contributes to a deeper understanding of oxidative stress, bioenergetic disturbances, and cardiotoxic mechanisms, with broader implications for public health and therapeutic innovation. Beyond his laboratory and scholarly pursuits, Dr. Aghebat Bekheir’s research emphasizes societal relevance by addressing environmental toxicants and their impacts on human health, providing foundational knowledge for developing interventions to mitigate toxicity-related diseases. Through his professional memberships, editorial activities, and collaborative initiatives, he actively contributes to shaping the global toxicology landscape, promoting evidence-based strategies, and inspiring emerging researchers in the field. His ongoing research underscores a commitment to integrating scientific excellence with practical solutions for human health, reflecting both scholarly distinction and societal impact. He has 23 citations from 5 documents with an h-index of 3.

Profiles: Google Scholar | Scopus

Featured Publications

1. Ghanati, K., Jahanbakhsh, M., Shakoori, A., Aghebat-Bekheir, S., … (2024). The association between polycystic ovary syndrome and environmental pollutants based on animal and human study; a systematic review.

2. Ghanati, K., Eghbaljoo, H., Akbari, N., Mazaheri, Y., Aghebat-Bekheir, S., … (2023). Determination of melamine contamination in milk with various packaging: A risk assessment study.

3. Aghebat-Bekheir, S., Abdollahi, M. (2024). Discovering the most impactful treatments for aluminum phosphide cardiotoxicity gleaned from systematic review of animal studies.

4. Reihani, A., Marboutian, F., Aghebat-Bekheir, S., Reyhani, A., Akhgari, M. (2024). Diagnostic aspects of paraquat in the forensic toxicology: A systematic review.

5. Aghebat-Bekheir, S., Hekmatirad, S., Asar, N., Abdollahi, M. (n.d.). Aluminum phosphide as a model for exploring acute mitochondrial disorders.

Showkat Ahmad Bhat | Translational Research | Editorial Board Member

Published on by Health Scientists

Dr. Showkat Ahmad Bhat | Translational Research | Editorial Board Member

Associate Professor | Deptt. of Biochemistry, Govt. Medical College Handwara | India

Dr. Showkat Ahmad Bhat is an accomplished biochemist and academic leader whose work spans clinical biochemistry, cancer biology, molecular biology, proteomics, and communicable diseases, reflecting a career dedicated to advancing both fundamental understanding and applied biomedical research. As an Associate Professor in the Department of Biochemistry at Government Medical College Handwara, he has developed a strong interdisciplinary portfolio with widely cited contributions across diverse domains, including the pharmacological potential of natural compounds, heavy metal toxicity, inflammatory mediators in metabolic disorders, animal and poultry health, and infectious disease pathogenesis. His research on bioactive phytochemicals such as zingerone, naringenin, and D-limonene has provided valuable insights into antioxidant, anti-inflammatory, and organ-protective mechanisms, while his work on microbial threats such as Salmonella, gastrointestinal parasites, and foot-and-mouth disease has informed both veterinary and public health perspectives. Dr. Bhat has collaborated extensively with national and international researchers, contributing to reviews, experimental studies, and translational investigations published in reputable journals spanning medical, veterinary, and biochemical sciences. His scholarship also extends to emerging fields such as epigenetic markers and microRNAs in breast cancer, reflecting his commitment to integrating molecular diagnostics with clinical needs. Beyond research, he has helped shape scientific understanding in the Kashmir region by addressing local health challenges, supporting capacity-building, and promoting evidence-based approaches in clinical biochemistry and infectious disease management. His cumulative body of work underscores a sustained commitment to improving human and animal health through rigorous inquiry, multidisciplinary collaboration, and the pursuit of innovative, socially relevant solutions. He has 546 citations from 28 documents with an h-index of 10.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Bilal Ahmad, S. B., Rehman, M. U., Amin, I., Arif, A., Rasool, S., … (2015). A review on pharmacological properties of zingerone (4-(4-hydroxy-3-methoxyphenyl)-2-butanone). The Scientific World Journal.

2. Bhat, S. A., Hassan, T., & Majid, S. (2019). Heavy metal toxicity and their harmful effects on living organisms: A review. International Journal of Medical Science and Diagnosis Research.

3. Dar, R. A. S. N. A. G. M. A., Ahmad, S. M., Bhat, S. A., Ahmed, R., Urwat, U., Mumtaz, P. T., … (2017). Salmonella typhimurium in poultry: A review. World’s Poultry Science Journal.

4. Bashir, A. H., Bhat, S. A., Majid, S., & Hamid, R. (2020). Role of inflammatory mediators (TNF-α, IL-6, CRP), biochemical and hematological parameters in type 2 diabetes mellitus patients of Kashmir, India. Medical Journal of the Islamic Republic of Iran.

5. Reshi, M. R. M. A., Husain, I., Bhat, S. A., Rehman, M. U., & Razak, R. (2015). Bovine mastitis as an evolving disease and its impact on the dairy industry. International Journal of Current Research and Review.

Emine Afşin | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Assoc. Prof. Dr. Emine Afşin | Clinical Medicine | Best Researcher Award 

Associate Professor | Bolu Abant Izzet Baysal University | Turkey

Dr. Emine Afşin is a distinguished medical professional and academic whose career reflects a deep commitment to advancing respiratory medicine and public health through clinical excellence, scientific research, and education. As an Associate Professor at Bolu Abant İzzet Baysal University, she has built a robust portfolio of contributions that span clinical practice, scholarly publications, and multidisciplinary collaborations. Her expertise lies in pulmonary diseases, clinical epidemiology, and patient-centered care, with a strong focus on improving diagnostic accuracy and therapeutic outcomes for individuals affected by chronic and infectious respiratory conditions. Dr. Afşin’s research encompasses a wide range of studies addressing disease pathophysiology, healthcare delivery, and preventive interventions, consistently demonstrating her dedication to evidence-based medicine. Her published works in reputable national and international journals have been widely cited, reflecting the impact and relevance of her findings within the global medical community. Through active participation in collaborative research projects, professional societies, and academic conferences, she has fostered strong partnerships that bridge clinical practice and scientific inquiry. Beyond academia, Dr. Afşin is recognized for her role in enhancing healthcare quality, mentoring young physicians, and advocating for equitable access to respiratory health services. Her work continues to contribute meaningfully to both medical science and society, emphasizing innovation, ethics, and human-centered approaches to healthcare advancement. She has 23 citations from 23 documents with an h-index of 2.

Profiles: Google Scholar | Scopus | ORCID
Featured Publications

1. Yılmazer, M., Altındiş, M., Cevrioğlu, S., Fenkci, V., Aktepe, O., & Sırthan, E. (2004). Afyon Bölgesinde yaşayan gebe kadınlarda toksoplazma, sitomegalovirus, rubella, hepatit B, hepatit C seropozitiflik oranları. Afyon Kocatepe Üniversitesi Kocatepe Tıp Dergisi.

2. Oğurlu, M., Sen, S., Polatli, M., Sırthan, E., Gürsoy, F., & Cildağ, O. (2007). The effect of spinal anesthesia on pulmonary function tests in old patients. Tuberkuloz ve Toraks, 55(1), 64–70.

3. Afsin, E., Yaksi, O., Onal, A., & Bacaksiz, E. (2022). Tracheal schwannoma mimicking asthma. International Journal of Neuroscience, 134(5), 436–440. https://doi.org/10.1080/00207454.2021.1999702

4. Afşin, E., & Demirkol, M. E. (2022). Post-COVID pulmonary function test evaluation. Turkish Thoracic Journal, 23(5), 345–350. https://doi.org/10.5152/TurkThoracJ.2022.22023

5.Afşin, E., & Cosgun, Z. (2021). A rare cough complication: Internal oblique muscle hematoma. Radiology Case Reports, 16(5), 1015–1018. https://doi.org/10.1016/j.radcr.2021.01.067

Tana Takacova | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Dr. Tana Takacova | Clinical Medicine | Best Researcher Award

Oncologist | Asklepios Klinik Altona | Germany

Tana Takacova is a physician-scientist specializing in hematology, oncology, and internal medicine with a distinguished academic and clinical trajectory across leading European research and tertiary care institutions. Her expertise spans immuno-oncology, molecular oncology, hematologic malignancies, and translational cancer research, supported by advanced training in oncology from a major German university and extensive postgraduate exposure to molecular biosciences in the United States. She has held clinical roles in prominent university-affiliated hospitals, progressing through multidisciplinary departments including hematology, oncology, palliative medicine, internal medicine, rheumatology, nephrology, gastroenterology, and cardiology, complemented by ongoing training as a prehospital emergency physician. Dr. Takacova has contributed to multiple international research collaborations across Germany, Denmark, Italy, and Slovakia, advancing knowledge in cancer genetics, circulating tumor DNA, oncolytic virus-checkpoint inhibitor synergies, renal cell carcinoma biomarkers, and therapy response prediction. Her peer-reviewed scholarship includes original research articles, systematic reviews, and case-based contributions in oncology and immunology, with additional manuscripts in review and development, reflecting a sustained commitment to evidence-based innovation and emerging therapeutic paradigms in precision oncology. She has presented at international oncology and pharmacology congresses and participates in global research networks and professional societies, reinforcing a truly international academic presence. Her work integrates advanced laboratory skills, clinical trial supervision, systematic review methodology, and bioinformatics-supported analysis, underscoring strong translational orientation. She has been recognized by competitive research fellowships and academic awards and contributes to open-access medical knowledge through educational initiatives such as a freely accessible hematology atlas. Fluent in multiple languages and trained across diverse health systems, she brings a global perspective, resilience in high-pressure environments, and a collaborative approach to clinical care and research leadership, driven by a commitment to advancing cancer diagnostics, therapeutic precision, and equitable patient outcomes worldwide. She has 34 citations from 4 documents with an h-index of 2.

Profile: Scopus

Featured Publications

1. Tana Takacova (2025). Paraneoplastic papillitis as a precursor to colon carcinoma: A case of unexpected vision loss leading to early cancer detection. Oncology Research and Treatment.

Serhat Gürbüz | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Dr. Serhat Gürbüz | Clinical Medicine | Best Researcher Award 

Doctor of Medicine | University of Health Sciences | Turkey

Dr. Serhat Gürbüz, MD, MSc, is a distinguished Consultant in Orthopedics and Traumatology at the Metin Sabancı Baltalimanı Bone Diseases Training and Research Hospital, University of Health Sciences, Istanbul, Turkey. His professional expertise centers on knee, shoulder, and sports surgery, integrating advanced arthroscopic techniques and evidence-based rehabilitation strategies to restore function and improve patient outcomes. Dr. Gürbüz has contributed substantially to the field through scholarly publications in reputable peer-reviewed and indexed journals, clinical presentations, and collaborative research projects focused on musculoskeletal disorders and joint preservation. His work demonstrates a commitment to combining clinical excellence with translational research, contributing to the evolution of orthopedic surgical standards and innovations in minimally invasive procedures. He has maintained active collaborations with national and international orthopedic research groups and serves as a peer reviewer and academic contributor within the global orthopedic community. Dr. Gürbüz’s clinical practice reflects a deep dedication to advancing patient-centered care, surgical innovation, and academic mentorship, fostering the development of future orthopedic specialists. His academic engagement and research productivity underscore his contribution to scientific knowledge dissemination and the enhancement of evidence-based orthopedic medicine. Through his multidisciplinary collaborations and continuous pursuit of clinical innovation, Dr. Gürbüz has strengthened the bridge between medical research and practical application, ultimately promoting better musculoskeletal health and improving the quality of life for patients across diverse populations. He has 6 citations from 9 documents with an h-index of 2.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Çelikoyar, M. M., Topsakal, O., & Gürbüz, S. (2019). Mobile technology for recording surgical procedures. Journal of Visual Communication in Medicine.

2. Imren, Y., Karslioglu, B., Dedeoglu, S. S., Cabuk, H., Atar, S., Gürbüz, S., … (2021). The effect of gluteus maximus tenotomy in primary total hip arthroplasty with posterior approach: Kinematic analysis of hip extensor strength. Journal of Orthopaedic Surgery.

3. Yüce, A., Yerli, M., Erkurt, N., Gürbüz, S., Çakar, M., & Adaş, M. (2022). Neutrophil-lymphocyte and C-reactive protein–albumin ratios as predictors of re-surgery in adult native knee septic arthritis. Journal of Clinical and Investigative Surgery.

4. Gürbüz, S., Bahar, H., Yavuz, U., Keskin, A., Karslioglu, B., & Solak, Y. (2025). Comparative efficacy of ChatGPT and DeepSeek in addressing patient queries on gonarthrosis and total knee arthroplasty. Arthroplasty Today.

5. Gürbüz, S., Ocak, O., Kir, M. C., Karslioglu, B., & Aki, S. (2025). Hyperchloremia at hospital admission for hip fractures is related with an increase in morbidity and mortality rates. Turkish Journal of Trauma and Emergency Surgery.

Dr. Serhat Gürbüz’s work advances global orthopedic science through innovative surgical techniques, evidence-based clinical research, and multidisciplinary collaborations that enhance musculoskeletal health. His commitment to patient-centered innovation and translational research contributes significantly to improving mobility, recovery, and quality of life in society worldwide.

Pradeep Kumar Chand | Translational Research | Best Health Biotechnology Award

Published on by Health Scientists

Prof. Pradeep Kumar Chand | Translational Research | Best Health Biotechnology Award 

Former Vice Chancellor | Utkal University | India

Prof. (Dr.) Pradeep Kumar Chand is a distinguished academician and researcher, currently serving as Chairperson of NAAC Peer Teams constituted by the National Assessment and Accreditation Council (Government of India) and formerly the Vice Chancellor of a State University. He earned his B.Sc. (Botany Hons.) and M.Sc. (Botany) with top distinctions and obtained his Ph.D. in Science from a reputed university in the United Kingdom, specializing in Plant Biotechnology and Genetic Engineering. With over 37 years of teaching and research experience, Prof. Chand’s pioneering contributions encompass plant tissue culture, genetic transformation, somatic hybridization, DNA fingerprinting, biogenic nanotechnology, and phytochemical analysis. He has guided numerous postgraduate research scholars, including several Ph.D. and M.Phil. awardees, and has authored numerous research papers in reputed international and national journals. His work in green nanotechnology and nano-onco-therapeutics has earned wide academic recognition. Prof. Chand has been honored with prestigious fellowships from organizations such as the DBT, DST, and INSA, and has served as a Biotechnology Overseas Associate under the Government of India’s Department of Biotechnology. His research collaborations with globally recognized institutions in Europe, Asia, and the United States highlight his international scientific engagement. Additionally, Prof. Chand has held editorial and peer-review roles in several scientific journals, contributing significantly to advancing research standards in biotechnology and plant sciences both nationally and internationally. He has 2333 citations from 81 documents with an h-index of 27.

Profiles: Google Scholar | Scopus

Featured Publications

1. Genetically transformed root extracts of medicinal plant Sida acuta Burm.f. attenuate hyperglycemic effects in induced diabetic rats. (2025). Plant Cell, Tissue and Organ Culture.

2. Validation of PCR amplicon-based directed amplified minisatellite DNA (DAMD) markers for analysis of population structure and fruit trait association of promising Indian mangoes. (2025). Genetic Resources and Crop Evolution.

3. Hexavalent chromium bioaccumulation mediated enhancement of pyrethrin production in African marigold (Tagetes erecta L.): a promising plant for phytoremediation. (2023). Acta Physiologiae Plantarum.

4. Silver nanocrystals bio-fabricated using Rhizobium rhizogenes-transformed in vitro root extracts demonstrate health proactive properties. (2022). Bionanoscience.

5. Anthropogenic interventions regulate forest structure and carbon stock in transitional dry forests of Similipal Biosphere Reserve, India. (2022). Ecoscience.

Milad Rahimzadegan | Pharmacology | Best Academic Researcher Award

Published on by Health Scientists

Assist. Prof. Dr. Milad Rahimzadegan | Pharmacology | Best Academic Researcher Award

Assistant Professor | Shahid Beheshti University of Medical Sciences | Iran

Dr. Milad Rahimzadegan is an Assistant Professor at the Functional Neurosurgery Research Center, Shahid Beheshti University of Medical Sciences, and serves as R&D Manager in multiple pharmaceutical companies. He earned his PhD in Pharmacy-Toxicology and Pharmacology from Tehran University of Medical Sciences, followed by an M.Sc. in Medical Toxicology from Tarbiat Modares University, and a B.A. in Plant Medicine from the University of Tehran. Recently, he completed a post-doctoral fellowship focused on Artificial Intelligence in Neuroscience at the Functional Neurosurgery Research Center. Dr. Rahimzadegan’s research spans neuropharmacology, neurotoxicology, regenerative medicine, and advanced drug delivery systems, with particular emphasis on stem cell differentiation, conductive scaffolds for spinal cord injury, and nano-biosensing for cardiovascular and neurodegenerative diseases. He has authored numerous high-impact publications in journals including Stem Cell Reviews and Reports, International Journal of Biological Macromolecules, Materials Science & Engineering C, and Carbohydrate Polymers, and has contributed to multiple books on pharmacology, regenerative medicine, and neurosurgery. His work has been recognized with awards such as the Top Academic Secretary of USERN Iran, Young Scientific Award at Shahid Beheshti University, and membership in Iran’s National Elites Foundation. In addition to his research contributions, he serves as a reviewer and editorial board member for journals including Interventional Pain Medicine and Neuromodulation and International Clinical Neuroscience Journal, reflecting his commitment to advancing scientific knowledge and fostering innovation in neuroscience, pharmacology, and translational medicine. He has 326 citations from 26 documents with an h-index of 11.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Rahimzadegan, M., & Soodi, M. (2018). Comparison of memory impairment and oxidative stress following single or repeated doses administration of scopolamine in rat hippocampus.

2. Asl, S. K., & Rahimzadegan, M. (2022). The recent progress in the early diagnosis of acute myocardial infarction based on myoglobin biomarker: Nano-aptasensors approaches.

3. Malek-Khatabi, A., Razavi, M. S., Abdollahi, A., & Rahimzadeghan, M., et al. (2023). Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery.

4. Asl, S. K., Rahimzadegan, M., & Asl, A. K. (2024). Progress in cardiac tissue engineering and regeneration: Implications of gelatin-based hybrid scaffolds.

5. Asl, S. K., Rahimzadegan, M., & Ostadrahimi, R. (2024). The recent advancement in the chitosan hybrid-based scaffolds for cardiac regeneration after myocardial infarction.

Niladry Sekhar Ghosh | Oncology | Best Researcher Award

Published on by Health Scientists

Prof. Niladry Sekhar Ghosh | Oncology | Best Researcher Award

Professor | Assam Down Town University, Guwahati | India

Prof. Niladry Sekhar Ghosh is a distinguished researcher and Professor at Assam Down Town University, Guwahati, serving also as Member Secretary of the Board of Studies, with extensive expertise in pharmaceutical sciences, medicinal chemistry, and biomedical research. He earned his B.Pharm. and M.Pharm. degrees from S.C.S College of Pharmacy, R.G.U.H.S Bangalore, graduating with first-class honors, and completed his Ph.D. at Shobhit University in 2020, focusing on the synthesis of bioactive fluoro-benzothiazole derivatives and the biosynthesis of metallic nanoparticles for biological and pharmacological screening. With over 18 years of teaching experience and significant contributions to research, his key areas of interest include drug discovery, medicinal chemistry, nanotechnology-based drug delivery systems, pharmacological evaluation of bioactive compounds, and cancer therapeutics. Prof. Ghosh has authored more than 50 publications in high-impact journals indexed in SCI, Scopus, and ESCI, including studies on cathepsin inhibitors, benzimidazole and indole derivatives as anticancer agents, and green synthesis of nanoparticles. He has been recognized with multiple honors, notably the Young Teacher Awards by SPER in 2016 and 2018, and has secured competitive research grants from SERB-DST, DBT, ICMR, and NCW for innovative projects in pharmaceutical biotechnology and nanomedicine. Additionally, he holds patents for metallic nanoparticle synthesis and biomedical devices. Beyond research, he serves as a resource person, reviewer, and editor for various scientific journals, contributing to the dissemination of knowledge in medicinal chemistry, pharmacology, and nanotechnology. His leadership roles in academic administration and research guidance underscore his commitment to advancing pharmaceutical education and translational research. He has 90 citations from 22 documents with an h-index of 7.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Dubey, A., Ghosh, N. S., & Singh, R. (2022). Zebrafish as an emerging model: An important testing platform for biomedical science.

2. Dubey, A., Ghosh, N. S., Gupta, A., & Singh, S. (2023). A review on current epidemiology and molecular studies of lumpy skin disease virus—An emerging worldwide threat to domestic animals.

3. Dubey, A., Ghosh, N. S., Agnihotri, N., Kumar, A., Pandey, M., & Nishad, S. (2022). Herbs derived bioactive compounds and their potential for the treatment of neurological disorders.

4. Dubey, A., Ghosh, N. S., Rathor, V. P. S., Patel, S., Patel, B., & Purohit, D. (2022). SARS-CoV-2 infection leads to neurodegenerative or neuropsychiatric diseases.

5. Chandra, D., Yadav, I. K., Jaiswal, D., Ghosh, N., Singh, H. P., Mishra, A., … (Year not specified). Formulation and evaluation of satranidazole microspheres for colon-targeted drug delivery.